An authorized generic of Flector Patch (diclofenac epolamine topical patch) has been made available by Teva Pharmaceuticals for the topical treatment of acute pain due to minor strains, sprains, and contusions.
The FDA is restricting the use of codeine and tramadol medicines in children.
The American Society of Interventional Pain Physicians (ASIPP) has issued updated opioid prescribing guidelines for the management of patients with chronic, non-cancer pain.
A variety of factors may limit clinician willingness to prescribe naloxone, a potentially life-saving medication that counteracts the effects of opioid overdose.
Popular over-the-counter pain reliever acetaminophen may not only relieve a person’s pain, but may also blunt positive emotions.
New data shows a reduction in abuse, addiction, and opioid poisoning diagnoses following the introduction of reformulated oxycodone HCl extended-release tablets.
Based on preliminary analysis of a new survey, chronic pain patients are finding it harder to access hydrocodone combination products (HCP) after the Drug Enforcement Administration (DEA) rescheduling.
